Stanford study identifies six depression biotypes for personalized treatment

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 66 sec. here
  • 12 min. at publisher
  • 📊 Quality Score:
  • News: 61%
  • Publisher: 71%

Depression News

Medicine,Antidepressant,Anxiety

In the not-too-distant future, a screening assessment for depression could include a quick brain scan to identify the best treatment.

Stanford MedicineJun 17 2024

Around 30% of people with depression have what's known as treatment-resistant depression, meaning multiple kinds of medication or therapy have failed to improve their symptoms. And for up to two-thirds of people with depression, treatment fails to fully reverse their symptoms to healthy levels. Using a machine learning approach known as cluster analysis to group the patients' brain images, they identified six distinct patterns of activity in the brain regions they studied.

"To our knowledge, this is the first time we've been able to demonstrate that depression can be explained by different disruptions to the functioning of the brain," Williams said. "In essence, it's a demonstration of a personalized medicine approach for mental health based on objective measures of brain function."

One of the six biotypes uncovered in the study showed no noticeable brain activity differences in the imaged regions from the activity of people without depression. Williams believes they likely haven't explored the full range of brain biology underlying this disorder -; their study focused on regions known to be involved in depression and anxiety, but there could be other types of dysfunction in this biotype that their imaging didn't capture.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stanford study finds low risk of secondary blood cancers after CAR-T cell therapyA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy -; a cell-based cancer treatment that exploded on the scene in 2017 as a treatment for intractable blood cancers -; is low, despite a Food and Drug Administration warning.
Source: NewsMedical - 🏆 19. / 71 Read more »

Bird flu tests are hard to get. So how will we know when to sound the pandemic alarm?Stanford University infectious disease doctor Abraar Karan has seen a lot of patients with runny noses, fevers, and irritated eyes lately.
Source: NewsMedical - 🏆 19. / 71 Read more »

Risk of secondary cancers after CAR-T cell therapy low, according to large studyA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy—a cell-based cancer treatment that exploded on the scene in 2017 as a treatment for intractable blood cancers—is low, despite a Food and Drug Administration warning.
Source: medical_xpress - 🏆 101. / 51 Read more »

Night owl behavior could hurt mental health, sleep study findsNight owls, brace yourselves. A new study by Stanford Medicine researchers has found that following your natural inclination to stay awake until the early morning hours is a bad choice for your mental health.
Source: medical_xpress - 🏆 101. / 51 Read more »